Specifically, ICIs represented by programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) blockade were developed to reinvigorate exhausted T cells in the tumor microenvironment (6). This evidence concerns the gene PDCD1 and neoplasm.